[go: up one dir, main page]

CN113546260B - Method, device and storage medium for monitoring abnormal use of nasal high flow rate - Google Patents

Method, device and storage medium for monitoring abnormal use of nasal high flow rate Download PDF

Info

Publication number
CN113546260B
CN113546260B CN202110632978.XA CN202110632978A CN113546260B CN 113546260 B CN113546260 B CN 113546260B CN 202110632978 A CN202110632978 A CN 202110632978A CN 113546260 B CN113546260 B CN 113546260B
Authority
CN
China
Prior art keywords
flow rate
gas flow
flow
output pressure
nasal cannula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110632978.XA
Other languages
Chinese (zh)
Other versions
CN113546260A (en
Inventor
谢菲
胡兴硕
李丽娜
温若萱
杨庆云
黄皓轩
罗恢育
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Micomme Zhongjin Medical Technology Development Co Ltd
First Medical Center of PLA General Hospital
Original Assignee
Hunan Micomme Zhongjin Medical Technology Development Co Ltd
First Medical Center of PLA General Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Micomme Zhongjin Medical Technology Development Co Ltd, First Medical Center of PLA General Hospital filed Critical Hunan Micomme Zhongjin Medical Technology Development Co Ltd
Priority to CN202110632978.XA priority Critical patent/CN113546260B/en
Publication of CN113546260A publication Critical patent/CN113546260A/en
Application granted granted Critical
Publication of CN113546260B publication Critical patent/CN113546260B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/1005Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/12Preparation of respiratory gases or vapours by mixing different gases
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F30/00Computer-aided design [CAD]
    • G06F30/20Design optimisation, verification or simulation
    • G06F30/28Design optimisation, verification or simulation using fluid dynamics, e.g. using Navier-Stokes equations or computational fluid dynamics [CFD]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/1005Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • A61M2016/102Measuring a parameter of the content of the delivered gas
    • A61M2016/1025Measuring a parameter of the content of the delivered gas the O2 concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Algebra (AREA)
  • Fluid Mechanics (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Physics (AREA)
  • Pure & Applied Mathematics (AREA)
  • Computer Hardware Design (AREA)
  • Evolutionary Computation (AREA)
  • Geometry (AREA)
  • General Engineering & Computer Science (AREA)
  • Computing Systems (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

本发明涉及一种监测经鼻高流量使用异常的方法、装置和存储介质,所述方法通过获取经鼻高流量使用异常时的数据,并根据该数据进行拟合;然后获取经鼻高流量使用时预设的数据,并根据该预设的数据得到第二平均输出压力Fμ,将预设的流量值代入拟合公式中计算得到最大压力值Fmax;最后,将Fμ跟Fmax进行比较,进而能够客观、准确的确定经鼻高流量是否存在使用异常,从而避免经鼻高流量使用异常时所发生的误判现象。

The present invention relates to a method, device and storage medium for monitoring the abnormal use of high nasal flow. The method acquires the data of abnormal use of high nasal flow and performs fitting according to the data; then obtains the preset The data, and according to the preset data to get the second average output pressure F μ , put the preset flow value into the fitting formula to calculate the maximum pressure value F max ; finally, compare F μ with F max , and then It can objectively and accurately determine whether there is abnormal use of the nasal high flow rate, so as to avoid the misjudgment phenomenon that occurs when the nasal high flow rate is used abnormally.

Description

Method, apparatus and storage medium for monitoring for use anomalies in transnasal high flow
Technical Field
The invention relates to the technical field of respiratory support equipment, in particular to a method, a device and a storage medium for monitoring nasal high flow abnormal use.
Background
A nasal high-flow device such as a high-flow noninvasive respiratory humidification therapeutic instrument is an oxygen therapy device which directly transmits air-oxygen mixed high-flow gas with certain oxygen concentration to a patient through a nasal obstruction conduit without sealing, and in addition, the nasal high-flow device can calculate respiratory frequency by monitoring respiratory flow signals or pressure signals.
When the nasal high-flow device is abnormally used, the respiratory rate is displayed as 0, but at the moment, the respiratory flow signal or the pressure signal of the nasal high-flow device still has slight fluctuation, so that a misjudgment phenomenon is generated on a method for monitoring the respiratory rate by using the respiratory flow signal or the pressure signal.
Disclosure of Invention
The invention aims to provide a method, a device and a storage medium for monitoring the use abnormality of nasal high flow, which are used for solving the problem of misjudgment on a method for monitoring respiratory rate by using respiratory flow signals or pressure signals caused by the use abnormality of nasal high flow in the prior art.
In order to achieve the above purpose, the present invention provides the following technical solutions:
in a first aspect, embodiments of the present invention provide a method of monitoring for nasal high flow usage anomalies, the method comprising:
acquiring a first gas flow output when the nasal high flow is abnormal in use and a corresponding maximum first output pressure;
fitting according to the first gas flow and the corresponding maximum first output pressure to obtain a fitting formula: f (F) max =ω 2 *flow 21 *flow+ω 0 The method comprises the steps of carrying out a first treatment on the surface of the Wherein F is max Represents the maximum pressure value omega 2 、ω 1 、ω 0 Representing fitting parameters, and the flow represents the first gas flow;
acquiring a second gas flow preset during nasal high flow use and a plurality of corresponding second output pressures;
obtaining a second average output pressure F according to a plurality of the second output pressures μ
Substituting the second gas flow into a fitting formula to obtain F max
Will F μ Heel F max Comparison is performedTo realize the monitoring of the abnormal use of the nasal high flow.
In one possible embodiment, F μ Heel F max Comparing to enable monitoring of nasal high flow usage anomalies, comprising:
if F μ Greater than F max Determining that the nasal high flow rate is not abnormal in use; otherwise, it is determined that there is an abnormal use of the nasal high flow.
In one possible embodiment, fitting is performed according to the first gas flow rate and the corresponding maximum first output pressure, so as to obtain a fitting formula: f (F) max =ω 2 *flow 21 *flow+ω 0 Comprising:
taking the root mean square of the fitting formula as a loss function, calculating the deviation of the loss function, and obtaining omega 2 、ω 1 、ω 0
In one possible implementation, the loss function is:
wherein (1)>Representing a correction coefficient, i representing the number of fitted values, j representing the order of the fitting formula, L (ω) representing the loss function.
In one possible embodiment, a plurality of said second output pressures are obtained by collecting pressure data from 64-128 pressure sensors.
In one possible embodiment, the abnormal use includes the patient not wearing a nasal obstruction catheter and the worn nasal obstruction catheter loosening.
In one possible embodiment, the first gas flow rate and the second gas flow rate are each 10-80L/min;
the first output pressure F max 1-15cmH 2 O;
The second average output pressureF μ 1-28cmH 2 O。
In a second aspect, an embodiment of the present invention further provides an apparatus for monitoring for abnormal use of nasal high flow, including:
the acquisition module is used for acquiring the first gas flow, the second gas flow, the maximum first output pressure and the second output pressure;
the processing module is used for fitting according to the first gas flow and the corresponding maximum first output pressure, and calculating a second average output pressure F according to a plurality of second output pressures μ And is also used for substituting the second gas flow into a fitting formula to obtain F max
A determining module for determining F μ Heel F max The comparison is performed to achieve monitoring of the nasal high flow usage anomalies.
In one possible embodiment, the apparatus further comprises:
and the prompt module is used for giving a prompt when the use abnormality of the nasal high flow is determined.
In a third aspect, the present embodiments also provide a storage medium having a computer program stored therein, wherein the computer program is arranged to perform the method of any of the embodiments described above when run.
The technical scheme provided by the embodiment of the invention has the beneficial effects that at least:
firstly, acquiring data during abnormal nasal high flow use, and fitting according to the data; then obtaining preset data when the nasal high flow is used, and obtaining a second average output pressure F according to the preset data μ Substituting the preset flow value into a fitting formula to calculate a maximum pressure value F max The method comprises the steps of carrying out a first treatment on the surface of the Finally, F μ Heel F max By comparing, whether the nasal high flow is abnormal or not can be objectively and accurately determined, and therefore misjudgment phenomenon caused by abnormal nasal high flow is avoided.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions of the prior art, the drawings that are needed in the embodiments or the description of the prior art will be briefly described below, it will be obvious that the drawings in the following description are some embodiments of the present invention, and that other drawings can be obtained according to these drawings without inventive effort to a person skilled in the art.
FIG. 1 is a flow chart of a method for monitoring for high nasal flow usage anomalies provided by an embodiment of the present invention;
FIG. 2 is a schematic diagram of a device for monitoring nasal high flow abnormal use according to an embodiment of the present invention;
FIG. 3 is a schematic structural diagram of an apparatus for monitoring nasal high flow abnormal use according to another embodiment of the present invention shown in FIG. 2;
fig. 4 is a graph of a fitting curve of a fitting formula provided in an embodiment of the present invention.
Reference numerals illustrate:
11-an acquisition module;
12-a processing module;
13-a determination module;
14-prompting module.
Detailed description of the preferred embodiments
In this specification, each example or embodiment is described in a progressive manner, and each example is mainly described as different from other examples, and identical similar parts of each example are mutually referred to.
In the description of the present specification, the descriptions of the terms "one embodiment," "some embodiments," "illustrative embodiments," "examples," "specific examples," or "some examples," etc., mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the fuel tank of the present invention. In this specification, schematic representations of the above terms do not necessarily refer to the same embodiments or examples. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
Furthermore, the terms "first," "second," and the like, are used for descriptive purposes only and are not to be construed as indicating or implying a relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defining "a first" or "a second" may explicitly or implicitly include at least one such feature. In the description of the present invention, the meaning of "plurality" means at least two, for example, two, three, etc., unless specifically defined otherwise.
Referring to fig. 1, an embodiment of the present invention provides a method for monitoring nasal high flow usage anomalies, which includes the following steps:
step S101: acquiring a first gas flow output when the nasal high flow is abnormal in use and a corresponding maximum first output pressure;
the abnormal use of the nasal high flow comprises the loosening of the nasal obstruction catheter which is not worn or the nasal obstruction catheter which is worn, and the respiratory frequency is not displayed as 0 at the moment, so that misjudgment can be caused by judging the respiratory frequency. In the embodiment provided by the invention, the first gas flow which is output to the patient through the nasal high flow and the corresponding maximum first output pressure are obtained, wherein the nasal high flow is not worn by the nasal obstruction catheter, and it can be understood that the first output pressure can fluctuate within a certain range when the first gas flow is output, so that the numerical value of the maximum first output pressure can be acquired in order to accurately judge the abnormal use of the nasal high flow.
The first gas is usually air-oxygen mixed gas with a certain oxygen concentration, and the flow rate of the air-oxygen mixed gas is set at 10-80L/min. By way of example, the first gas flow rate may be, but is not limited to, 10L/min, 15L/min, 20L/min, 25L/min, 30L/min, 35L/min, 40L/min, 45L/min, 50L/min, 55L/min, 60L/min, 65L/min, 70L/min, 75L/min, 80L/min. In addition, the maximum first output pressure corresponding to the first gas flow is 1-15cmH 2 O. Specifically, reference may be made to table 1.
TABLE 1
Set flow (L/min) First gas flow (L/min) F max (cmH 2 O)
10 10.80 1.30
15 14.79 1.70
20 20.24 2.10
25 24.85 2.70
30 30.30 3.40
35 35.36 3.80
40 40.44 4.60
45 45.02 5.70
50 50.19 6.90
55 55.14 8.30
60 60.21 9.70
65 65.28 11.10
70 70.15 12.80
75 75.20 13.5
80 80.11 15.0
It should be noted that the duration and the data amount for each data acquisition can be adjusted according to the actual sampling frequency. For example, in the embodiment provided by the invention, the acquired data amount is 128, and the duration of each data acquisition is 12s, if the frequency is fast, the data amount can be increased appropriately; otherwise, the amount of data is reduced.
Step S102: fitting according to the first gas flow and the corresponding maximum first output pressure to obtain a fitting formula: f (F) max =ω 2 *flow 21 *flow+ω 0 The method comprises the steps of carrying out a first treatment on the surface of the Wherein F is max Represents the maximum pressure value omega 2 、ω 1 、ω 0 Representing fitting parameters, and the flow represents the first gas flow;
the step S102 specifically includes:
1) Fitting according to the first gas flow and the corresponding maximum first output pressure to obtain a fitting formula F max =ω 2 *flow 21 *flow+ω 0
2) The root mean square of the fitting formula is taken as a loss function, and the loss function isWherein (1)>Representing a correction coefficient which is a coefficient increased for calculation convenience, i representing the number of fitting values, j representing the order of the fitting formula, and L (ω) representing the loss function;
3) Deviation of the loss function, i.e.The following formula can be further derived:
the formula is that 8 data are collected and respectively substituted into the loss function of the deviation obtaining function to calculate omega 2 、ω 1 、ω 0
In a specific embodiment, ω is calculated 2 、ω 1 、ω 0 Then the fitting formula is F max =0.002*flow 2 +0.0268 flow+0.7606, curve asShown in fig. 3.
It should be noted that the measured gas flow and the maximum pressure value corresponding to the measured gas flow cannot be identical each time due to the influence of factors such as equipment, environment and the like, but R of the obtained fitting formula 2 (goodness of fit) is greater than 99%.
Step S103: and obtaining a second gas flow preset during nasal high flow use and a plurality of corresponding second output pressures.
In the embodiments provided herein, nasal obstruction catheters are worn by patients when used at high nasal flows. Then, the gas flow rate set in advance to the patient and the output pressure corresponding to the gas flow rate are acquired. As described above, since the second output pressure fluctuates within a certain range when the second gas flow rate is output, a plurality of second output pressures are collected so that the use abnormality of the transnasal high flow rate can be accurately determined. In one possible embodiment, 64 second output pressure values are collected and the sampling duration is about 5.5s (sampling frequency 90 ms).
The second gas is usually air-oxygen mixed gas with a certain oxygen concentration, and the flow rate of the second gas is set to be 10-80L/min. By way of example, the second gas flow may be, but is not limited to, 10L/min, 15L/min, 20L/min, 25L/min, 30L/min, 35L/min, 40L/min, 45L/min, 50L/min, 55L/min, 60L/min, 65L/min, 70L/min, 75L/min, 80L/min. In addition, the second output pressure corresponding to the second gas flow is 1-28cmH 2 O。
Step S104: obtaining a second average output pressure F from the plurality of second output pressures μ Reference may be made to table 2.
TABLE 2
It should be noted here that the simulation isThe maximum first output pressure is selected from the equation and the average output pressure is calculated in this step, mainly because: if the fitting formula and the actual value have certain difference values, the fitting and the subsequent calculation result are obtained through average pressure values, and when the numerical value obtained by the fitting formula is smaller than the actual value, erroneous judgment on the nasal high flow is easily caused, namely, the nasal high flow is abnormal in use, but the respiratory frequency is not 0. Therefore, in the embodiment provided by the invention, the maximum first output value is adopted in the fitting formula, and in the process of using the nasal high flow, the second average output pressure F is calculated by a plurality of second output pressures μ
Step S105: substituting the second gas flow into a fitting formula to obtain F max The results are shown in Table 1.
Step S106: will F μ Heel F max The comparison is performed to achieve monitoring of the nasal high flow usage anomalies.
In the examples provided in the present invention, if F μ Greater than F max Determining that the nasal high flow rate is not abnormal in use; otherwise, it is determined that there is an abnormal use of the nasal high flow.
Based on the same inventive concept, the embodiment of the present invention further provides a device for monitoring the usage abnormality of the nasal high flow, which can be used for implementing any one of the methods for monitoring the usage abnormality of the nasal high flow in the above embodiments, and will not be described herein.
Referring to fig. 2, the apparatus includes:
an acquisition module 11 for acquiring a first gas flow rate, a second gas flow rate, a maximum first output pressure and a second output pressure;
the processing module 12 is configured to perform fitting according to the first gas flow and the corresponding maximum first output pressure, and calculate a second average output pressure F according to the plurality of second output pressures μ And is also used for substituting the second gas flow into the fitting formula to obtain F max
A determining module 13 for determining F μ Heel F max Comparing to achieve high nasal flowMonitoring with anomalies.
In one possible embodiment, the acquisition module 11 is specifically configured to: 1) Acquiring a first gas flow output when the nasal high flow is abnormal in use and a corresponding maximum first output pressure; 2) And obtaining a second gas flow preset during nasal high flow use and a plurality of corresponding second output pressures.
In one possible embodiment, the processing module 12 is specifically configured to: 1) Fitting according to the first gas flow and the corresponding maximum first output pressure; 2) Obtaining a second average output pressure F from the plurality of second output pressures μ The method comprises the steps of carrying out a first treatment on the surface of the 3) Substituting the second gas flow into the fitting formula to obtain F max
In one possible embodiment, the determining module 13 is specifically configured to: will F μ Heel F max Comparing if F μ Greater than F max Determining that the nasal high flow rate is not abnormal in use; otherwise, it is determined that there is an abnormal use of the nasal high flow.
In one possible embodiment, referring to fig. 3, the apparatus further comprises:
and the prompt module is used for giving a prompt when the use abnormality of the nasal high flow is determined.
Based on the same inventive concept, the present embodiment also provides a storage medium having a computer program stored therein, wherein the computer program is configured to perform the method of monitoring for a transnasal high flow usage abnormality described in any of the above embodiments at run-time.
The storage medium may include a high-speed RAM memory and may also include a non-volatile memory (non-volatile memory), such as at least one magnetic disk memory. It is understood that the storage medium may be a random access memory (Random Access Memory, RAM), a magnetic disk, a hard disk, a Solid State Disk (SSD), or a nonvolatile memory, or the like, which may be a variety of machine readable media that can store the program code.
It should be apparent to those skilled in the art that embodiments of the present invention may be provided as a method, apparatus, or storage medium. Accordingly, embodiments of the present invention may take the form of an entirely hardware embodiment, an entirely software embodiment or an embodiment combining software and hardware aspects. Furthermore, embodiments of the invention may take the form of a computer program product on one or more computer-usable storage media (including, but not limited to, disk storage, CD-ROM, optical storage, etc.) having computer-usable program code embodied therein.
Embodiments of the present invention are described with reference to flowchart illustrations and/or block diagrams of methods, apparatus, and computer program products according to embodiments of the invention. It will be understood that each flow and/or block of the flowchart illustrations and/or block diagrams, and combinations of flows and/or blocks in the flowchart illustrations and/or block diagrams, can be implemented by computer program instructions. These computer program instructions may be provided to a processor of a general purpose computer, special purpose computer, embedded processor, or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor of the computer or other programmable data processing apparatus, create means for implementing the functions specified in the flowchart flow or flows and/or block diagram block or blocks.
These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means which implement the function specified in the flowchart flow or flows and/or block diagram block or blocks.
These computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the functions specified in the flowchart block or blocks and/or block diagram block or blocks
Finally, it should be noted that: the above embodiments are only for illustrating the technical solution of the present invention, and not for limiting the same; although the invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme recorded in the foregoing embodiments can be modified, or the technical features of the parts or all parts can be replaced equivalently; such modifications and substitutions do not depart from the spirit of the invention.

Claims (10)

1.一种监测经鼻高流量使用异常的方法,其特征在于,所述方法包括:1. A method for monitoring abnormal use of high-flow nasal cannula medication, characterized in that the method comprises: 获取经鼻高流量使用异常时输出的第一气体流量及所对应的最大第一输出压力;Obtain the first gas flow rate and the corresponding maximum first output pressure when the high-flow nasal cannula is used abnormally; 根据所述第一气体流量以及所对应的最大第一输出压力进行拟合,得到拟合公式:Fmax=ω2*flow21*flow+ω0;其中,Fmax表示最大压力值,ω2、ω1、ω0表示拟合参数,flow表示第一气体流量;The fitting formula is obtained by fitting the first gas flow rate and the corresponding maximum first output pressure: F max = ω 2 * flow 2 + ω 1 * flow + ω 0 ; where F max represents the maximum pressure value, ω 2 , ω 1 , and ω 0 represent the fitting parameters, and flow represents the first gas flow rate; 获取经鼻高流量使用时预设的第二气体流量及所对应的多个第二输出压力;Obtain the preset second gas flow rate and corresponding multiple second output pressures when using high-flow nasal cannula; 根据多个所述第二输出压力得到第二平均输出压力FμThe second average output pressure is obtained based on multiple second output pressures; 将所述第二气体流量代入拟合公式中得到FmaxSubstituting the second gas flow rate into the fitting formula yields Fmax ; 将Fμ跟Fmax进行比较,以实现对经鼻高流量使用异常的监测。 is compared with Fmax to enable monitoring of abnormal use of high-flow nasal cannula. 2.根据权利要求1所述的方法,其特征在于,将Fμ跟Fmax进行比较,以实现对经鼻高流量使用异常的监测,包括:2. The method according to claim 1, characterized in that comparing with Fmax to monitor abnormal use of high-flow nasal cannula, includes: 若Fμ大于Fmax,则确定经鼻高流量不存在使用异常;否则,确定经鼻高流量存在使用异常。If is greater than Fmax , then it is determined that there is no abnormality in the use of the high-flow nasal cannula; otherwise, it is determined that there is an abnormality in the use of the high-flow nasal cannula. 3.根据权利要求1或2所述的方法,其特征在于,根据所述第一气体流量以及所对应的最大第一输出压力进行拟合,得到拟合公式:Fmax=ω2*flow21*flow+ω0,包括:3. The method according to claim 1 or 2, characterized in that, fitting is performed based on the first gas flow rate and the corresponding maximum first output pressure to obtain the fitting formula: Fmax = ω2 * flow2 + ω1 * flow + ω0 , including: 将所述拟合公式的均方根作为损失函数,对所述损失函数求偏导,计算得到ω2、ω1、ω0Using the root mean square of the fitted formula as the loss function, and taking the partial derivative of the loss function, we can calculate ω2 , ω1 , and ω0 . 4.根据权利要求3所述的方法,其特征在于,所述损失函数为:4. The method according to claim 3, wherein the loss function is: 其中,表示修正系数,i表示拟合数值的数量,j表示为所述拟合公式的阶数,L(ω)表示为所述损失函数。 in, Let represent the correction coefficient, i represent the number of fitted values, j represent the order of the fitting formula, and L(ω) represent the loss function. 5.根据权利要求1所述的方法,其特征在于,多个所述第二输出压力通过64-128个压力传感器采集压力数据得到的。5. The method according to claim 1, wherein the plurality of second output pressures are obtained by collecting pressure data through 64-128 pressure sensors. 6.根据权利要求1所述的方法,其特征在于,所述使用异常包括患者未佩戴鼻塞导管和佩戴的鼻塞导管松动。6. The method according to claim 1, wherein the abnormality of use includes the patient not wearing a nasal cannula and the worn nasal cannula being loose. 7.根据权利要求1所述的方法,其特征在于,所述第一气体流量和所述第二气体流量均为10-80L/min;7. The method according to claim 1, wherein the first gas flow rate and the second gas flow rate are both 10-80 L/min; 所述第一输出压力Fmax为1-15cmH2O;The first output pressure Fmax is 1-15 cmH2O ; 所述第二平均输出压力Fμ为1-28cmH2O。The second average output pressure is 1-28 cmH2O . 8.一种监测经鼻高流量使用异常的装置,其特征在于,包括:8. A device for monitoring abnormal use of high-flow nasal cannula, characterized in that it comprises: 获取模块,用于获取第一气体流量、第二气体流量、最大第一输出压力和第二输出压力;The acquisition module is used to acquire the first gas flow rate, the second gas flow rate, the maximum first output pressure, and the second output pressure; 处理模块,用于根据所述第一气体流量以及所对应的最大第一输出压力进行拟合,还用于根据多个第二输出压力计算得到第二平均输出压力Fμ,以及还用于将所述第二气体流量代入拟合公式中得到FmaxThe processing module is used to fit the first gas flow rate and the corresponding maximum first output pressure, and is also used to calculate the second average output pressure based on multiple second output pressures, and to substitute the second gas flow rate into the fitting formula to obtain Fmax . 确定模块,用于将Fμ跟Fmax进行比较,以实现对经鼻高流量使用异常的监测。The determination module is used to compare with Fmax to monitor abnormal use of high-flow-rate nasal cannula. 9.根据权利要求8所述的装置,其特征在于,所述装置还包括:9. The apparatus according to claim 8, wherein the apparatus further comprises: 提示模块,用于在确定经鼻高流量存在使用异常时给出提示。The alert module is used to provide an alert when it is determined that there is an abnormality in the use of high-flow nasal cannula. 10.一种存储介质,其特征在于,所述存储介质中存储有计算机程序,其中,所述计算机程序被设置为运行时执行权利要求1-7任一项中所述的方法。10. A storage medium, characterized in that the storage medium stores a computer program, wherein the computer program is configured to execute the method described in any one of claims 1-7 when running.
CN202110632978.XA 2021-06-07 2021-06-07 Method, device and storage medium for monitoring abnormal use of nasal high flow rate Active CN113546260B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110632978.XA CN113546260B (en) 2021-06-07 2021-06-07 Method, device and storage medium for monitoring abnormal use of nasal high flow rate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110632978.XA CN113546260B (en) 2021-06-07 2021-06-07 Method, device and storage medium for monitoring abnormal use of nasal high flow rate

Publications (2)

Publication Number Publication Date
CN113546260A CN113546260A (en) 2021-10-26
CN113546260B true CN113546260B (en) 2023-08-22

Family

ID=78102013

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110632978.XA Active CN113546260B (en) 2021-06-07 2021-06-07 Method, device and storage medium for monitoring abnormal use of nasal high flow rate

Country Status (1)

Country Link
CN (1) CN113546260B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104707228A (en) * 2015-03-02 2015-06-17 深圳市科曼医疗设备有限公司 Transnasal high-flow-capacity oxygen therapy pressure monitoring system and method
CN104771818A (en) * 2015-03-02 2015-07-15 深圳市科曼医疗设备有限公司 Self-adaptation calibration system and method for passing-nose pressure generator
CN107205694A (en) * 2015-02-12 2017-09-26 皇家飞利浦有限公司 Estimate while the respiration parameter being fitted by the region of respiration parameter
CN108245749A (en) * 2017-12-29 2018-07-06 湖南明康中锦医疗科技发展有限公司 Respiratory flow method of counting, device, computer equipment and medium
CN112402752A (en) * 2020-09-14 2021-02-26 湖南明康中锦医疗科技发展有限公司 Respiration support method and respiration support device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118286549A (en) * 2017-11-22 2024-07-05 费雪派克医疗保健有限公司 Respiration rate monitoring for respiratory flow therapy systems
US11298484B2 (en) * 2018-05-14 2022-04-12 General Electric Company Method and systems for executing nasal high flow therapy with settings determined from flow outputs during a previous ventilation mode

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107205694A (en) * 2015-02-12 2017-09-26 皇家飞利浦有限公司 Estimate while the respiration parameter being fitted by the region of respiration parameter
CN104707228A (en) * 2015-03-02 2015-06-17 深圳市科曼医疗设备有限公司 Transnasal high-flow-capacity oxygen therapy pressure monitoring system and method
CN104771818A (en) * 2015-03-02 2015-07-15 深圳市科曼医疗设备有限公司 Self-adaptation calibration system and method for passing-nose pressure generator
CN108245749A (en) * 2017-12-29 2018-07-06 湖南明康中锦医疗科技发展有限公司 Respiratory flow method of counting, device, computer equipment and medium
CN112402752A (en) * 2020-09-14 2021-02-26 湖南明康中锦医疗科技发展有限公司 Respiration support method and respiration support device

Also Published As

Publication number Publication date
CN113546260A (en) 2021-10-26

Similar Documents

Publication Publication Date Title
JP6878589B2 (en) Systems and methods for monitoring and determining patient parameters from sensed venous waveforms
JP5587022B2 (en) Method and device for determining a recommended value for an active ingredient dose based on a series of measurements of at least one physiological parameter of a patient
Hodgson et al. Nasal high flow therapy for primary respiratory support in preterm infants
WO2012008544A1 (en) Hemodialysis system
JP6622402B2 (en) Anesthesia ventilator that performs automatic ventilation and identifies operating conditions related to automatic ventilation
CN111479500A (en) System and method for filtering medical device noise artifacts from venous waveform signals
SE538864C2 (en) Method System and Software for Protective Ventilation
CN114616004A (en) Dialysis system with continuous glucose monitoring
JP6250183B2 (en) Monitoring device for monitoring the state of a patient's circulatory system and computer program for the monitoring
CN104703534B (en) Method for detecting indications of morbid events in dialysis by measuring relative blood volume, blood pressure and heart rate
CN113546260B (en) Method, device and storage medium for monitoring abnormal use of nasal high flow rate
CN113521461B (en) Method, device and storage medium for monitoring nasal high flow usage state
RU2015155889A (en) METHOD AND SYSTEM FOR COLLECTING ANALYTICAL INFORMATION ON VENTILATED PATIENTS
US20210213217A1 (en) Airway anomaly recognition method, ventilation device, and storage medium
CN101107024B (en) heart disease treatment system
US11458233B2 (en) Method for detecting intravascular volume depletion during a hemodialysis session
US20190343408A1 (en) System and method for monitoring and determining patient parameters from sensed venous waveform
CN117643663A (en) Method, apparatus and computer readable storage medium for detecting ventilation occlusion event
CN112107767B (en) A monitoring index providing method and device, ventilation equipment and storage medium
JP2016530594A (en) Evaluation device for essential requirements of pharmacotherapy and / or paramedical care, evaluation method for executing the evaluation device, and related delivery device
Chakravarthy et al. Index of consciousness and bispectral index values are interchangeable during normotension and hypotension but not during non pulsatile flow state during cardiac surgical procedures: a prospective study
Tanaka et al. Impulse oscillometry; therapeutic impacts of transdermal long-acting Beta-2 agonist patch in elderly asthma with inhaled corticosteroid alone
CN113874061A (en) Method and device for measuring gas concentration, medical ventilation equipment, and storage medium
Majumdar et al. Estimating the diameter of airways susceptible for collapse using crackle sound
Zhang et al. The Analysis of Nocturnal Blood Pressure Changes Associated Parameters in Obstructive Sleep Apnea Patients in a Teaching Hospital

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant